FDA
approval
· 2017-04-07
FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
Summary
The FDA approved a supplemental application for EMTRIVA (emtricitabine) from Gilead Sciences.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for EMTRIVA (EMTRICITABINE)